Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The pharmacokinetics and clinical tolerability of ascending single doses of BNC210 in healthy volunteers.

Next Previous
Trial Profile

The pharmacokinetics and clinical tolerability of ascending single doses of BNC210 in healthy volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BNC 210 (Primary)
  • Indications Anxiety disorders
  • Focus Adverse reactions; Pharmacokinetics

    • Most Recent Events

    • 28 Aug 2010 Results presented at the 23rd Annual Congress of the European College of Neuropsychopharmacology.
    • 03 Mar 2010 Clinical Trial Results Confirm Safety and Indicate Reduced Stress Hormone Levels, according to a media release from Bionomics.
    • 08 Dec 2009 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top